Transcriptomics Market to move forward at a double-digit CAGR by 2026
                     Transcriptomics Market growing at a 
CAGR of 13.8% | Strategic Analysis and 
Future Scenarios – 2026
Transcriptomics Market by Technology (Microarray, Real-time PCR, and Sequencing Technology), Products & Services 
(Consumables, Instruments, Software, and Services), Application (Diagnostics & Disease Profiling, Drug Discovery, and 
Others), and End User (Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, and 
Contract Research Organization) - Global Opportunity Analysis and Industry Forecast, 2018-2026
Why Allied Market Research?
FREQUENTLY ASKED QUESTIONS?
INFALLIBLE METHODOLOGY
To ensure high-level data integrity, accurate analysis, and 
impeccable forecasts Q1. What is the total market value of 
Transcriptomics market report?
ANALYST SUPPORT
For complete satisfaction Q2. What would be forecast period in 
the market report?
CUSTOMIZATION
Q3. What is the market value of 
On-demand customization of scope of the report to exactly meet 
your needs Transcriptomics market in 2020?
TARGETED MARKET VIEW Q4. Which is base year calculated in 
the Transcriptomics market report?
Targeted market view to provide pertinent information and save 
time of readers Q5. Which are the top companies hold 
the market share in Transcriptomics 
market?
Overview
According to a new report published by Allied Market 
Research, titled, "Transcriptomics Market by Technology, 
Products & Services, Application, and End User: Global 
Opportunity Analysis and Industry Forecast, 2017-2023," 
global transcriptomics market was valued at $3,212 million in 
2016, and is projected to reach $7,954 million by 2023, 
growing at a CAGR of 13.8% from 2017 to 2023. Real-time 
PCR segment held more than two-fifths share of the total 
market in 2016.
Increase in technological advancements and rise in research 
grants by various institutes is expected to drive the market 
growth. In addition, the potential of RNAs to act as 
candidates for diagnostic biomarkers and predictors of drug 
response are anticipated to further drive the demand for 
transcriptomics globally. 
Segments
In terms of revenue, the global surgical robotics market is 
segmented on the basis of Product Technology, Product & 
Services, Application and End User. 
By Application - Drug discovery application led the overall 
transcriptomics market, and accounted for nearly three-fifths 
of the total market in 2016.
By Technology- Sequencing technology is projected to 
grow at highest CAGR of 15.1% during the forecast period. 
qPCR technology segment occupied nearly half of the global 
transcriptomics market in 2016. Based on technology, it is 
divided into microarray, real time-PCR (qPCR), and 
sequencing. 
Geography
North America dominated the Transcriptomics 
market. The market growth in North America is 
primarily a reflection of product innovations and 
launches resulting from technological advancements. 
The companies mostly adopted product launch, 
acquisition, and expansion as their key strategies to 
keep pace with the changing demands of consumers 
and strengthen their market position.
Key Market Players
The key players operating in the global Transcriptomics market are 
• QIAGEN (Exiqon)
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• Agilent Technologies.
• GE Healthcare Dharmacon Inc.
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Fluidigm Corporation.
• Promega Corporation.
• An in-depth market analysis includes analysis of various 
regions, which is anticipated to provide a detailed 
Key Findings of the understanding of the current trends to enable 
stakeholders formulate region-specific plans.
Transcriptomics • A comprehensive analysis of factors that drive and 
market: restrain the growth of the global is provided.
• The projections in this report are made by analyzing the 
current trends and future market potential from 2021 to 
2030, in terms of value.
Find out more at the Allied Market Report store
https://www.alliedmarketresearch.com/transcriptomics-market
ABOUT ALLIED MARKET RESEARCH
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in 
Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched 
quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business 
insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their 
respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us 
generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented 
in the reports published by us is extracted through primary interviews with top officials from leading companies of domain 
concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with 
knowledgeable professionals and analysts in the industry.
Contact:  
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com